Human diamine oxidase is readily released from activated neutrophils ex vivo and in vivo but is rarely elevated in bacteremic patients.


Journal

International journal of immunopathology and pharmacology
ISSN: 2058-7384
Titre abrégé: Int J Immunopathol Pharmacol
Pays: England
ID NLM: 8911335

Informations de publication

Date de publication:
Historique:
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 14 7 2021
Statut: ppublish

Résumé

During human diamine oxidase (DAO) ELISA development we noticed that in serum DAO concentrations appear to be higher when compared to plasma. Neutrophils contain DAO in the specific granules and we hypothesized that DAO is released from neutrophils during serum coagulation. If activation of neutrophils can release DAO, its concentrations might be elevated in vivo after lipopolysaccharide (LPS) administration and in bacteremic patients. Using blood from healthy volunteers DAO concentrations were measured ex vivo in serum, citrate, EDTA and heparin plasma over several hours and after activation of neutrophils. Lipopolysaccharide and granulocyte-colony stimulating factor (G-CSF) were administered to 15 and 8 healthy volunteers, respectively and DAO concentrations were measured at different timepoints. DAO antigen levels were also determined in three different subcohorts of patients with culture-proven bacteremia and high C-reactive protein (CRP) levels. DAO concentrations were elevated in a time-dependent manner in serum but not in EDTA or citrate plasma (

Identifiants

pubmed: 32997559
doi: 10.1177/2058738420954945
pmc: PMC7533923
doi:

Substances chimiques

Biomarkers 0
Lipopolysaccharides 0
Granulocyte Colony-Stimulating Factor 143011-72-7
DAO protein, human EC 1.4.3.-
D-Amino-Acid Oxidase EC 1.4.3.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2058738420954945

Références

PLoS One. 2013 Dec 11;8(12):e82946
pubmed: 24349403
Am J Obstet Gynecol. 1964 May 15;89:199-203
pubmed: 14144412
J Clin Rheumatol. 2002 Apr;8(2):67-71
pubmed: 17041325
J Clin Invest. 1979 Jun;63(6):1195-202
pubmed: 109469
J Immunol. 1983 Jul;131(1):439-44
pubmed: 6223078
J Leukoc Biol. 2012 Feb;91(2):275-84
pubmed: 22075928
Am J Physiol. 1960 Jun;198:1187-92
pubmed: 14442502
Wien Klin Wochenschr. 2013 May;125(9-10):239-43
pubmed: 23579881
Allergo J Int. 2017;26(2):72-79
pubmed: 28344921
Digestion. 1986;34(4):243-50
pubmed: 3091435
J Exp Med. 1976 Oct 1;144(4):1049-61
pubmed: 824399
Clin Biochem. 2017 May;50(7-8):444-451
pubmed: 28041932
Scand J Clin Lab Invest. 1969 Sep;24(2):163-8
pubmed: 4986445
Clin Pharmacol Ther. 2017 Jun;101(6):773-781
pubmed: 27864832
J Clin Invest. 1983 Nov;72(5):1672-7
pubmed: 6556194
J Biol Inorg Chem. 2002 Jun;7(6):565-79
pubmed: 12072962
Sci Rep. 2018 Apr 20;8(1):6342
pubmed: 29679053
Inflamm Res. 2009 Apr;58 Suppl 1:51-2
pubmed: 19271146
J Leukoc Biol. 2011 Mar;89(3):359-72
pubmed: 21097697
Lab Invest. 1991 May;64(5):656-63
pubmed: 2030580
J Biotechnol. 2016 Jun 10;227:120-130
pubmed: 27063138
Inflamm Res. 2003 Apr;52 Suppl 1:S63-4
pubmed: 12755413
Int J Immunopathol Pharmacol. 2016 Mar;29(1):105-11
pubmed: 26574488
Thromb Haemost. 1988 Jun 16;59(3):360-3
pubmed: 3187929
Scand J Rheumatol. 1992;21(6):283-8
pubmed: 1475638
Obstet Gynecol. 1972 Mar;39(3):426-30
pubmed: 4623064
Br J Haematol. 1996 Jun;93(3):558-68
pubmed: 8652373
Crit Care Med. 1996 Oct;24(10):1670-7
pubmed: 8874304
J Clin Invest. 1982 Mar;69(3):564-72
pubmed: 6916769
Shock. 1994 Apr;1(4):299-306
pubmed: 7537617
Agents Actions. 1990 Nov;31(3-4):263-74
pubmed: 2085142
J Chromatogr. 1988 Sep 9;430(2):249-62
pubmed: 3235501
J Physiol. 1930 Dec 4;70(4):349-72
pubmed: 16994147
Clin Exp Immunol. 1988 Sep;73(3):484-8
pubmed: 2463123
Eur J Intern Med. 2015 Dec;26(10):782-6
pubmed: 26586287
Scand J Clin Lab Invest. 1995 Apr;55(2):125-31
pubmed: 7667605
J Lab Clin Med. 1991 Dec;118(6):576-84
pubmed: 1720802
J Clin Invest. 1961 Sep;40:1631-7
pubmed: 13714470
Crit Care Med. 1989 Jan;17(1):30-5
pubmed: 2909318
J Rheumatol. 1992 May;19(5):689-92
pubmed: 1613696
Allergy. 2019 Mar;74(3):583-593
pubmed: 30418682
Clin Exp Med. 2017 May;17(2):243-249
pubmed: 27002713

Auteurs

Thomas Boehm (T)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Matthias Karer (M)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Peter Matzneller (P)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Nina Buchtele (N)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Franz Ratzinger (F)

Division of Medical and Chemical Laboratory Diagnostics, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Karin Petroczi (K)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Christian Schoergenhofer (C)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Michael Schwameis (M)

Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.

Heinz Burgmann (H)

Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Markus Zeitlinger (M)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Bernd Jilma (B)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH